Results 71 to 80 of about 38,963 (252)

Ella Eld Folder

open access: yes, 1974
10 pages of family history documents containing and related to Ella Eld; - including: Index; 1974 Mother of the Year Award; obit; Finnish; News ...
Ella Eld;
core  

Classical Complement Pathway Inhibition in a Pediatric Patient With Refractory Immune Thrombocytopenia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric refractory immune thrombocytopenia (rITP) is generally characterized by persistent thrombocytopenia and failure to achieve a sustained response to multiple standard therapies. We report a 4‐year‐old female with congenital tufting enteropathy, post‐intestinal transplant patient on immunosuppressants, who developed severe rITP ...
Sarah Hsieh   +4 more
wiley   +1 more source

Hypercalcemia and acute kidney injury induced by eldecalcitol in patients with osteoporosis: a case series of 32 patients at a single facility

open access: yesRenal Failure, 2019
Background: Eldecalcitol (ELD) is an active vitamin D3 analog that is widely used in Japan for the treatment of osteoporosis. The most common adverse drug reaction of ELD is hypercalcemia.
Seishi Aihara   +6 more
doaj   +1 more source

Bill Eld Folder

open access: yes, 1982
2 pages of family history documents containing and related to William "Bill" T.
William "Bill" T. Eld
core  

Evidence‐Based Clinical Practice Guidelines for the Management of Pediatric Febrile Neutropenia: Resource‐Sensitive Recommendations for the Asian Continent

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Febrile neutropenia (FN) is a frequent and serious complication in children receiving cancer therapy. Standardizing FN management across Asia is challenging due to variable healthcare infrastructure, diagnostic capacity, and infection patterns; however, it could improve resource use and patient outcomes.
Joliza Patricia Cañeba   +29 more
wiley   +1 more source

ELD Initiative: User Guide_A 6+1 step approach to assess the economics of land management

open access: yes, 2016
ELD Initiative: User Guide_A 6+1 step approach to assess the economics of land ...
Favretto, Nicola
core  

Eosinophil deficiency and HpARI2 treatment reduce ELD-induced lung lacunarity.

open access: yes
(A) Representative lung tissue sections of naïve, MF-challenged (MF), ELD, dblGATA ELD and HpARI2-treated ELD mice (ELD-HpARI) stained with hematoxylin and eosin ten days after MF challenge. (B) Lacunarity of 5 μm lung tissue sections.
Joséphine Gal (14000010)   +11 more
core   +1 more source

Abatacept for Prophylaxis of Acute and Chronic Graft‐Versus‐Host‐Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation—A Systematic Review and Meta‐Analysis of Cohort Studies

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Graft‐versus‐host disease (GvHD) remains one of the most significant complications of hematopoietic stem cell transplantation (HSCT). Abatacept, a selective T‐cell costimulation modulator, is a relatively novel prophylactic agent, though pediatric data remain limited.
Matthijs D. Kruizinga   +3 more
wiley   +1 more source

Simulation Analysis of High Voltage Electrical Box Electric Field for Centralized Power EMUs

open access: yes机车电传动, 2020
According to the principle of main circuit for centralized power EMUs in China, the high voltage electrical box equipped with two main circuit breakers was researched and designed, which not only optimized the arrangement of roof equipments, but also ...
Congjian JIANG, Tao LI, Yingyu YANG
doaj  

Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy